Haemonetics
HAE
#3422
Rank
ยฃ3.02 B
Marketcap
ยฃ62.78
Share price
2.32%
Change (1 day)
-4.52%
Change (1 year)

Operating Margin for Haemonetics (HAE)

Operating Margin as of December 2025 (TTM): 15.58%

According to Haemonetics's latest financial reports and stock price the company's current Operating Margin is 15.58%. At the end of 2025 the company had an Operating Margin of 15.58%.

Operating Margin history for Haemonetics from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202515.58%34.33%
202411.60%-4.12%
202312.10%88.86%
20226.41%-23.52%
20218.38%-5%
20208.82%15.86%
20197.61%15.36%
20186.60%-312.76%
2017-3.10%-47.24%
2016-5.88%-271.69%
20153.42%-11.74%
20143.88%-30.66%
20135.59%-54.51%
201212.30%-24.41%
201116.27%29.19%
201012.59%-11.43%
200914.22%-5.02%
200814.97%-6.96%
200716.09%-36.82%
200625.46%63.23%
200515.60%24.03%
200412.58%9.78%
200311.46%-4.79%
200212.03%104.1%
20015.90%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Thermo Fisher Scientific
TMO
16.22% 4.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
13.68%-12.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
8.81%-43.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
-11.51%-173.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-2.44%-115.66%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
14.13%-9.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78% 20.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78% 7.70%๐Ÿ‡ฎ๐Ÿ‡ช Ireland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.